Masataka Seike

4.4k total citations
54 papers, 2.4k citations indexed

About

Masataka Seike is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Masataka Seike has authored 54 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Epidemiology, 20 papers in Hepatology and 9 papers in Surgery. Recurrent topics in Masataka Seike's work include Liver Disease Diagnosis and Treatment (25 papers), Liver Disease and Transplantation (9 papers) and Hepatitis C virus research (9 papers). Masataka Seike is often cited by papers focused on Liver Disease Diagnosis and Treatment (25 papers), Liver Disease and Transplantation (9 papers) and Hepatitis C virus research (9 papers). Masataka Seike collaborates with scholars based in Japan, United States and Netherlands. Masataka Seike's co-authors include Hironobu Yoshimatsu, Takayuki Masaki, Seiichi Chiba, Mizuki Endo, Hitoshi Noguchi, Hiroshi Tatsukawa, Tohru Yasuda, Mie Arakawa, Tooru Shimosegawa and Isao Sakaida and has published in prestigious journals such as PLoS ONE, Hepatology and Diabetes.

In The Last Decade

Masataka Seike

53 papers receiving 2.4k citations

Peers

Masataka Seike
Masataka Seike
Citations per year, relative to Masataka Seike Masataka Seike (= 1×) peers Motoh Iwasa

Countries citing papers authored by Masataka Seike

Since Specialization
Citations

This map shows the geographic impact of Masataka Seike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masataka Seike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masataka Seike more than expected).

Fields of papers citing papers by Masataka Seike

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masataka Seike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masataka Seike. The network helps show where Masataka Seike may publish in the future.

Co-authorship network of co-authors of Masataka Seike

This figure shows the co-authorship network connecting the top 25 collaborators of Masataka Seike. A scholar is included among the top collaborators of Masataka Seike based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masataka Seike. Masataka Seike is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Endo, Mizuki, Koichi Honda, Tomoko Saito, et al.. (2021). Maximum Plasma Concentration of Lenvatinib Is Useful for Predicting Thrombocytopenia in Patients Treated for Hepatocellular Carcinoma. World Journal of Oncology. 12(5). 165–172. 4 indexed citations
2.
Gotoh, Koro, Yoko Kudo, Mie Arakawa, et al.. (2020). α‐Tocopherol suppresses hepatic steatosis by increasing CPT‐1 expression in a mouse model of diet‐induced nonalcoholic fatty liver disease. Obesity Science & Practice. 7(1). 91–99. 9 indexed citations
3.
Gotoh, Koro, Mie Arakawa, Mizuki Endo, et al.. (2020). Supplementation of branched-chain amino acids decreases fat accumulation in the liver through intestinal microbiota-mediated production of acetic acid. Scientific Reports. 10(1). 18768–18768. 44 indexed citations
4.
Yamada, Yasunari, Shunro Matsumoto, Hiromu Mori, et al.. (2017). Periportal lymphatic system on post-hepatobiliary phase Gd-EOB-DTPA-enhanced MR imaging in normal subjects and patients with chronic hepatitis C. Abdominal Radiology. 42(10). 2410–2419. 5 indexed citations
5.
Honda, Koichi, Masataka Seike, Mizuki Endo, et al.. (2016). Risk factors for deterioration of long-term liver function after radiofrequency ablation therapy. World Journal of Hepatology. 8(13). 597–597. 3 indexed citations
6.
Watanabe, Sumio, Etsuko Hashimoto, Kenichi Ikejima, et al.. (2015). Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Journal of Gastroenterology. 50(4). 364–377. 268 indexed citations
7.
Gotoh, Koro, Megumi Inoue, Takayuki Masaki, et al.. (2012). A Novel Anti-inflammatory Role for Spleen-Derived Interleukin-10 in Obesity-Induced Inflammation in White Adipose Tissue and Liver. Diabetes. 61(8). 1994–2003. 64 indexed citations
8.
Inoue, Megumi, Masataka Seike, Takayuki Masaki, et al.. (2012). High alanine aminotransferase level as a predictor for the incidence of macrovascular disease in type 2 diabetic patients with fatty liver disease. Hepatology International. 7(2). 555–561. 2 indexed citations
9.
Gotoh, Koro, Megumi Inoue, Takayuki Masaki, et al.. (2012). Spleen-Derived Interleukin-10 Downregulates the Severity of High-Fat Diet-Induced Non-Alcoholic Fatty Pancreas Disease. PLoS ONE. 7(12). e53154–e53154. 39 indexed citations
11.
Gotoh, Koro, Megumi Inoue, Takayuki Masaki, et al.. (2011). A novel anti‐inflammatory role for spleen‐derived interleukin‐10 in obesity‐induced hypothalamic inflammation. Journal of Neurochemistry. 120(5). 752–764. 32 indexed citations
12.
Inoue, Megumi, Koro Gotoh, Masataka Seike, et al.. (2011). Involvement of remnant spleen volume on the progression of steatohepatitis in diet‐induced obese rats after a splenectomy. Hepatology Research. 42(2). 203–212. 5 indexed citations
13.
Kumada, Hiromitsu, Takeshi Okanoue, Morikazu Onji, et al.. (2010). Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan. Hepatology Research. 40(1). 8–13. 81 indexed citations
14.
15.
Chayama, Kazuaki, C. Nelson Hayes, Kentaro Yoshioka, et al.. (2010). Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C. Hepatology Research. 40(12). 1155–1167. 18 indexed citations
16.
Kumada, Hiromitsu, Takeshi Okanoue, Morikazu Onji, et al.. (2010). Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan. Hepatology Research. 40(1). 1–7. 93 indexed citations
17.
Iwaki, Kentaro, Masayuki Ohta, Seiichiro Kai, et al.. (2008). Metastasis of hepatocellular carcinoma to spleen and small intestine. Journal of Hepato-Biliary-Pancreatic Surgery. 15(2). 213–219. 11 indexed citations
18.
Seike, Masataka, Satoshi Fukuchi, Takayuki Masaki, et al.. (2008). Heterozygosity for leptin receptor (fa) accelerates hepatic triglyceride accumulation without hyperphagia in Zucker rats. Obesity Research & Clinical Practice. 3(1). 29–34. 6 indexed citations
19.
Hamaguchi, Kazuyuki, et al.. (2000). Novel mutations of the ATP7B gene in Japanese patients with Wilson disease. Journal of Human Genetics. 45(2). 86–91. 27 indexed citations
20.
Takahashi, Naohiko, et al.. (1992). A Case of Primary Biliary Cirrhosis Associated with Hashimoto's Thyroiditis, Scleroderma and Sjoegren's Syndrome.. Internal Medicine. 31(3). 418–421. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026